Pluristem
Therapeutics, a developer of placenta-based cell therapies, has been granted
Patent (No. 261087) from India's Office of the Controller General of Patents,
Designs & Trade Marks for a patent titled, "Methods for Cell Expansion
and Conditioned Media Produced Thereby for Therapy."
The Patent was already granted to Pluristem in Australia, Russia and South Africa.
Pluristem was founded in the year 2001 by SHai Merelkzi and is engaged in developing of human placental adherent stromal cells
The Patent was already granted to Pluristem in Australia, Russia and South Africa.
Pluristem was founded in the year 2001 by SHai Merelkzi and is engaged in developing of human placental adherent stromal cells
0 comments:
Post a Comment